Literature DB >> 1402787

Cell-bound peptidase activities of Treponema denticola ATCC 33520 in continuous culture.

F H Mikx1, F Jacobs, C Satumalay.   

Abstract

The oral spirochaete Treponema denticola ATCC 33520 was grown at a mean generation time of 10 h in anaerobic continuous culture in a serum- and carbohydrate-free medium at pH 7.0. The extracellular proteolytic activities of this spirochaete were then investigated by incubating washed cells with 68 2-naphthylamide derivatives of the Extended API System. Chymotrypsin-like, trypsin-like, elastase-like and iminopeptidase activities were demonstrated. The phenylalanine peptidase or chymotrypsin-like activity of T. denticola ATCC 33520, estimated with N-succinyl-L-phenylalanyl-L-leucyl-L-phenylalanine-thiobenzyl ester (SPLP) had a pH optimum at pH 8.5, a specific activity of 36.6 nmol min-1 (mg dry wt)-1 and was inhibited only slightly by HgCl2. The trypsin-like activity, estimated with benzoyl-DL-arginine-7-amido-4-methylcoumarin (BAMC), had a pH optimum at pH9, and a specific activity of 0.3 nmol min-1 (mg dry wt)-1; inhibition by HgCl2 indicated the involvement of active thiol groups. The activity should preferably be termed arginine peptidase activity, according to the carboxy-terminal amino acid of the test substrate. The extracellular proline peptidase activity, estimated with L-proline-7-amido-4-methylcoumarin. HBr (PRAMC), had an activity of 1.5 nmol min-1 (mg dry wt)-1, an optimum at pH 8.5 and the properties of a thiol protease. The main cell-bound and extracellular active peptidase activities of fast-growing cells of T. denticola ATCC 33520 are phenylalanine peptidase, proline peptidase, arginine peptidase and an oligopeptide-dependent alanine peptidase activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402787     DOI: 10.1099/00221287-138-9-1837

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  9 in total

1.  Genetic and transcriptional analysis of flgB flagellar operon constituents in the oral spirochete Treponema denticola and their heterologous expression in enteric bacteria.

Authors:  H F Heinzerling; M Olivares; R A Burne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Filamentous actin disruption and diminished inositol phosphate response in gingival fibroblasts caused by Treponema denticola.

Authors:  P F Yang; M Song; D A Grove; R P Ellen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Virulence characteristics of oral treponemes in a murine model.

Authors:  L Kesavalu; S G Walker; S C Holt; R R Crawley; J L Ebersole
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

4.  Cloning and sequence analysis of a chymotrypsinlike protease from Treponema denticola.

Authors:  S Arakawa; H K Kuramitsu
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Role of the chymotrypsin-like membrane-associated proteinase from Treponema denticola ATCC 35405 in inactivation of bioactive peptides.

Authors:  P L Mäkinen; K K Mäkinen; S A Syed
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Phylogenetic analysis of pathogen-related oral spirochetes.

Authors:  B K Choi; C Wyss; U B Göbel
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

7.  Dentilisin activity affects the organization of the outer sheath of Treponema denticola.

Authors:  K Ishihara; H K Kuramitsu; T Miura; K Okuda
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

8.  Competitive and interactions affecting a fermentative spirochete in anaerobic chemostats.

Authors:  S L Dollhopf; M L Pariseau; S A Hashsham; J M Tiedje
Journal:  Microb Ecol       Date:  2003-07       Impact factor: 4.552

9.  Degradation of endogenous plasma membrane fibronectin concomitant with Treponema denticola 35405 adhesion to gingival fibroblasts.

Authors:  R P Ellen; M Song; C A McCulloch
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.